Biphasic blood pool contrast agent-enhanced whole-body mr angiography for treatment planning in patients with significant arterial stenosis

Investigative Radiology

Volumn 44, Issue 7, 2009, Pages 422-432

  Huppertz, Alexander ^a   Kroll, Hannes ^b   Klessen, Christian ^a   Taupitz, Matthias ^a   Rückert, Ralph I ^c   Schröder, Ralf Juergen ^a   Albrecht, Thomas ^a   Frericks, Bernd ^c   Voth, Matthias ^d   Wagner, Moritz ^a   Hamm, Bernd ^a   Asbach, Patrick ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Franziskus Hospital   (Germany)

^d BAYER PHARMA AG   (Germany)

Author keywords

Contrast agent; Gadofosveset; Intravascular contrast agent; Magnetic resonance angiography; Steady state; Whole body imaging

Indexed keywords

GADOFOSVESET;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTERY OCCLUSION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIGITAL SUBTRACTION ANGIOGRAPHY; DRUG TOLERABILITY; FEMALE; HUMAN; IMAGE QUALITY; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TREATMENT PLANNING;

EID: 67651015721     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e3181a4d8bf     Document Type: Article

References (44)

1. Borisch I, Horn M, Butz B, et al. Preoperative evaluation of carotid artery stenosis: comparison of contrast-enhanced MR angiography and duplex sonography with digital subtraction angiography. Am J Neuroradiol. 2003; 24:1117-1122.
2. Randoux B, Marro B, Koskas F, et al. Proximal great vessels of aortic arch: comparison of three-dimensional gadolinium-enhanced MR angiography and digital subtraction angiography. Radiology. 2003;229:697-702.
3. De Cobelli F, Venturini M, Vanzulli A, et al. Renal arterial stenosis: prospective comparison of color Doppler US and breath-hold, three-dimensional, dynamic, gadolinium-enhanced MR angiography. Radiology. 2000; 214:373-380.
4. Dormandy J, Heeck L, Vig S. Lower-extremity arteriosclerosis as a reflection of a systemic process: implications for concomitant coronary and carotid disease. Semin Vasc Surg. 1999;12:118-122.
5. von Kemp K, van den Brande P, Peterson T, et al. Screening for concomitant diseases in peripheral vascular patients. Results of a systematic approach. Int Angiol. 1997;16:114-122.
6. Goyen M, Quick HH, Debatin JF, et al. Whole-body three-dimensional MR angiography with a rolling table platform: initial clinical experience. Radiology. 2002;224:270-277.
7. Leiner T, de Vries M, Hoogeveen R, et al. Contrast-enhanced peripheral MR angiography at 3.0 Tesla: initial experience with a whole-body scanner in healthy volunteers. J Magn Reson Imaging. 2003;17:609 -614.
8. Kruger DG, Riederer SJ, Grimm RC, et al. Continuously moving table data acquisition method for long FOV contrast-enhanced MRA and whole-body MRI. Magn Reson Med. 2002;47:224-231.
9. Ruehm SG, Goyen M, Barkhausen J, et al. Rapid magnetic resonance angiography for detection of atherosclerosis. Lancet. 2001;357:1086-1091.
10. Vasbinder GB, Nelemans PJ, Kessels AG, et al. for the Renal Artery Diagnostic Imaging Study in Hypertension (RADISH) Study Group. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med. 2004;141:674-682.
11. Janka R, Wenkel E, Fellner C, et al. Magnetic resonance angiography of the peripheral vessels in patients with peripheral arterial occlusive disease: when is an additional conventional angiography required? Cardiovasc Intervent Radiol. 2006;29:220-229.
12. Berg F, Bangard C, Bovenschulte H, et al. Feasibility of peripheral contrast- enhanced magnetic resonance angiography at 3.0 Tesla with a hybrid technique: comparison with digital subtraction angiography. Invest Radiol. 2008;43:642-649.
13. Andreisek G, Pfammatter T, Goepfert K, et al. Peripheral arteries in diabetic patients: standard bolus-chase and time-resolved MR angiography. Radiology. 2007;242:610-620.
14. Lüdemann L, Nafz B, Elsner F, et al. Absolute quantification of regional renal blood flow in swine by dynamic contrast-enhanced magnetic resonance imaging using a blood pool contrast agent. Invest Radiol. In press.
15. Frenzel T, Lengsfeld P, Schirmer H, et al. Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees. Invest Radiol. 2008;43:817-828.
16. Michaely HJ, Attenberger UI, Dietrich O, et al. Feasibility of gadofosveset- enhanced steady-state magnetic resonance angiography of the peripheral vessels at 3 Tesla with Dixon fat saturation. Invest Radiol. 2008;43:635-641.
17. Parmelee DJ, Walovitch RC, Ouellet HS, et al. Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging. Invest Radiol. 1997;32:741-747.
18. Rohrer M, Bauer H, Mintorovitch J, et al. Comparison ofmagnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol. 2005;40:715-724.
19. Klessen C, Hein PA, Huppertz A, et al. First-pass whole-body magnetic resonance angiography (MRA) using the blood-pool contrast medium gado- fosveset trisodium: comparison to gadopentetate dimeglumine. Invest Radiol. 2007;42:659-664.
20. Nikolaou K, Kramer H, Grosse C, et al. High-spatial-resolution multistation MR angiography with parallel imaging and blood pool contrast agent: initial experience. Radiology. 2006;241:861-72.
21. Klessen C, Asbach P, Hein PA, et al. Whole-body MR angiography: comparison of two protocols for contrast media injection. Rofo. 2006;178:484-490.
22. European Carotid Surgery Trialists Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70%-99%) or with mild (0%-29%) carotid stenosis. Lancet. 1991;337:1235-1243.
23. Ota H, Takase K, Rikimaru H, et al. Quantitative vascular measurements in arterial occlusive disease. Radiographics. 2005;25:1141-1158.
24. Obuchowski N. On the comparison of correlated proportions for clustered data. Stat Med. 1998;17:1495-1507.
25. Ruehm SG, Goyen M, Quick HH, et al. Whole-body MRA on a rolling table platform (AngioSURF). Rofo. 2000;172:670-674.
26. Goyen M, Herborn CU, Kroger K, et al. Detection of atherosclerosis: systemic imaging for systemic disease with whole-body three-dimensional MR angiography-initial experience. Radiology. 2003;227:277-282.
27. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329-1339.
28. Coccheri S. Distribution of symptomatic atherothrombosis and influence of atherosclerotic disease burden on risk of secondary ischaemic events: results from CAPRIE [abstract]. Eur Heart J. 1998;19(suppl):227.
29. Fowkes FG, Low LP, Tuta S, et al. for the AGATHA Investigators. Ankle- brachial index and extent of atherothrombosis in 8891 patients with or at risk ofvascular disease: results ofthe international AGATHA study. Eur Heart J. 2006;27:1861-1867.
30. Ruehm SG, Goehde SC, Goyen M. Whole body MR angiography screening. Int J Cardiovasc Imaging. 2004;20:587-591.
31. Ladd SC, Debatin JF, Stang A, et al. Whole-body MR vascular screening detects unsuspected concomitant vascular disease in coronary heart disease patients. Eur Radiol. 2007;17:1035-1045.
32. Nael K, Ruehm SG, Michaely HJ, et al. Multistation whole-body high-spatial- resolution MR angiography using a 32-channel MR system. Am J Roentgenol. 2007;188:529 -539.
33. Fleischmann D, Rubin GD. Quantification of intravenously administered contrast medium transit through the peripheral arteries: implications for CT angiography. Radiology. 2005;236:1076-1082.
34. Nelemans PJ, Leiner T, de Vet HC, et al. Peripheral arterial disease: meta-analysis ofthe diagnostic performance of MR angiography. Radiology. 2000;217:105-114.
35. Nederkoorn PJ, van der Graaf Y, Hunink MG. Duplex ultrasound and magnetic resonance angiography compared with digital subtraction angiog- raphy in carotid artery stenosis: a systematic review. Stroke. 2003;34:1324-1332.
36. Schaefer PJ, Boudghene FP, Brambs HJ, et al. Abdominal and iliac arterial stenoses: comparative double-blinded randomized study of diagnostic accuracy of 3D MR angiography with gadodiamide or gadopentetate dimeglu-mine. Radiology. 2006;238:827-840.
37. Rutherford RB, Baker JD, Ernst C, et al. J Recommended standards for reports dealing with lower extremity ischemia: revised version. Vasc Surg. 1997;26:517-538.
38. Norgren L, Hiatt WR, Dormandy JA, et al on behalfofthe TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II) Eur J Vasc Endovasc Surg. 2007;33:S1-S70.
39. Goyen M, Herborn CU, Kroger K, et al. Total-body 3D magnetic resonance angiography influences the management of patients with peripheral arterial occlusive disease. Eur Radiol. 2006;16:685-691.
40. Clevert DA, Johnson T, Jung EM, et al. Color Doppler, power Doppler and B-flow ultrasound in the assessment of ICA stenosis: comparison with 64-MD-CT angiography. Eur Radiol. 2007;17:2149 -2159.
41. Collins R, Cranny G, Burch J, et al. A systematic review ofduplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease. Health Technol Assess. 2007;11:1-202.
42. Koelemay MJ, Legemate DA, de Vos H, et al. Duplex scanning allows selective use of arteriography in the management of patients with severe lower leg arterial disease. J Vasc Surg. 2001;34:661-667.
43. Herborn CU, Ajaj W, Goyen M, et al. Peripheral vasculature: whole-body MR angiography with midfemoral venous compression-initial experience. Radiology. 2004;230:872-878.
44. Asbach P, Warmuth C, Stemmer A, et al. High spatial resolution T1-weighted MR imaging of liver and biliary tract during uptake phase of a hepatocyte- specific contrast medium. Invest Radiol. 2008;43:809-815.